Aetna considers microwave, radiofrequency, or ultrasound ablation of the renal sympathetic nerve experimental, investigational, or unproven for hypertension, heart failure, acute myocardial infarction, cardiac arrhythmias, ventricular tachycardia, obstructive sleep apnea, chronic kidney-related pain and chronic renal failure; the list is not all-inclusive. Transurethral renal pelvic denervation using radiofrequency ablation and cryoablation of the renal sympathetic nerve are experimental, investigational, or unproven for hypertension and all other indications. The CPT codes 0338T, 0339T and 0935T and the ICD-10 codes listed in the policy are not covered for the indications listed in the policy.
Get alerts when payers change rules like this one
We check Aetna and other payers every day and email you when a change matches your specialty and state.
01Billing team: Do not bill CPT 0338T, 0339T or 0935T for the indications listed in this policy, because the policy lists them as not covered for those indications.
02Billing team: Treat microwave, radiofrequency or ultrasound renal sympathetic nerve ablation as experimental, investigational or unproven when billed for the listed indications, including hypertension.
03Billing team: Treat transurethral renal pelvic denervation using radiofrequency ablation and cryoablation of the renal sympathetic nerve as experimental, investigational or unproven for hypertension and all other indications.
Summaries are AI-assisted. Always confirm against the original payer notice.
What is PolicyChanges
One workspace for payer rules, prior auth, coding and compliance
Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.